C.H. ROBINSON WORLDWIDE INC
CHRWNASDAQ🏆 #622 by market capEarnings Nov 4US Equity
$149.71▲ $1.48 (+0.99%)
🌙 After hours$149.71▲ 0.00%Regular close · extended-hours price shownTrack CHRW
Get earnings, price moves & breaking news on Telegram
24h▲ 1.0%
7d▲ 0.1%
14d▼ 5.1%
30d▼ 0.5%
ytd▼ 6.9%
1y▲ 13.5%
🏦Market Cap
$17.65B
Mid Cap
📈Revenue Growth (YoY)
-0.1%
Declining
📊Gross Margin
16.3%
Thin
💵FCF Margin
3.6%
Moderate
⚖️P/S Ratio
1.0x
Cheap
Otter Score
84
Good
C.H. ROBINSON WORLDWIDE INC
CHRWAnalyst Ratings
Price
$149.71
Total
46
Raised
6
Lowered
7
Avg PT
$194.50
H / L
$237 / $91
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citigroup | Upgraded | Neutral → Buy | 2026-09-08 | $120.00 | −19.80% |
Bernstein | Reiterated | Market Perform | 2026-08-11 | $151.00 | +0.90% |
Stifel | Reiterated | Buy | 2026-07-31 | — | — |
Stephens & Co. | Reiterated | Overweight | 2026-07-30 | — | — |
TD Cowen | Reiterated | Hold | 2026-07-30 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-07-30 | — | — |
Baird | Reiterated | Outperform | 2026-07-28 | — | — |
Truist Securities | Reiterated | Buy | 2026-07-15 | — | — |
Susquehanna | Reiterated | Positive | 2026-07-14 | $226.00 | +51.00% |
BMO Capital | Reiterated | Market Perform | 2026-07-14 | $190.00 | +26.90% |
Morgan Stanley | Reiterated | Underweight | 2026-07-06 | $91.00 | −39.20% |
Raymond James | Reiterated | Outperform | 2026-07-02 | $192.00 | +28.20% |
UBS | Reiterated | Buy | 2026-06-01 | $230.00 | +53.60% |
Jefferies | Upgraded | Hold → Buy | 2026-05-20 | $200.00 | +33.60% |
Wells Fargo | Reiterated | Overweight | 2026-04-30 | $185.00 | +23.60% |
Barclays | Reiterated | Overweight | 2026-04-30 | $210.00 | +40.30% |
JP Morgan | Reiterated | Overweight | 2026-04-30 | $87.00 | −41.90% |
B of A Securities | Reiterated | Buy | 2026-03-27 | — | — |
Freedom Broker | Reiterated | Hold | 2026-02-02 | — | — |
Benchmark | Reiterated | Buy | 2026-01-30 | — | — |
Goldman Sachs | Reiterated | Neutral | 2025-10-30 | $149.00 | −0.50% |
Deutsche Bank | Reiterated | Buy | 2025-10-02 | $220.00 | +47.00% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2025-07-01 | $196.00 | +30.90% |
TD Securities | Reiterated | Hold | 2025-05-01 | — | — |
Loop Capital | Reiterated | Buy | 2023-08-18 | — | — |
Credit Suisse | Reiterated | Underperform | 2023-08-16 | $93.00 | −37.90% |
Keybanc | Reiterated | Overweight | 2023-01-11 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2023-01-05 | — | — |
Vertical Research | Downgraded | Hold → Sell | 2022-08-17 | — | — |
Bank of America | Downgraded | Neutral → Underperform | 2019-10-30 | — | — |
KeyBanc | Downgraded | Overweight → Sector Weight | 2019-02-27 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-08-03 | $225.00 | +50.30% |
BB&T Capital | Downgraded | Buy → Hold | 2016-04-27 | — | — |
Buckingham Research | Reiterated | Buy | 2016-04-21 | — | — |
RBC Capital | Upgraded | Sector Perform → Outperform | 2016-01-07 | — | — |
Cleveland Research | Downgraded | Buy → Neutral | 2015-03-11 | — | — |
Nomura | Reiterated | Neutral | 2014-12-10 | — | — |
Macquarie | Reiterated | Neutral | 2014-10-15 | — | — |
Edward Jones | Upgraded | Sell → Hold | 2014-07-31 | — | — |
FBR Capital | Upgraded | Underperform → Market Perform | 2014-03-31 | — | — |
Wunderlich | Reiterated | Hold | 2014-02-06 | — | — |
Wunderlich Securities | Reiterated | Hold | 2014-02-06 | — | — |
Sterne Agee | Reiterated | Buy | 2012-10-23 | — | — |
Longbow Research | Reiterated | Neutral | 2012-08-09 | — | — |
Avondale Partners | Downgraded | Outperform → Market Perform | 2012-07-25 | — | — |
Oppenheimer | Reiterated | Perform | 2012-05-11 | — | — |
Institution
Citigroup
Upgraded · Neutral → Buy · 2026-09-08
$120.00
−19.80%
Bernstein
Reiterated · Market Perform · 2026-08-11
$151.00
+0.90%
Stifel
Reiterated · Buy · 2026-07-31
—
—
Stephens & Co.
Reiterated · Overweight · 2026-07-30
—
—
TD Cowen
Reiterated · Hold · 2026-07-30
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-07-30
—
—
Baird
Reiterated · Outperform · 2026-07-28
—
—
Truist Securities
Reiterated · Buy · 2026-07-15
—
—
Susquehanna
Reiterated · Positive · 2026-07-14
$226.00
+51.00%
BMO Capital
Reiterated · Market Perform · 2026-07-14
$190.00
+26.90%
Morgan Stanley
Reiterated · Underweight · 2026-07-06
$91.00
−39.20%
Raymond James
Reiterated · Outperform · 2026-07-02
$192.00
+28.20%
UBS
Reiterated · Buy · 2026-06-01
$230.00
+53.60%
Jefferies
Upgraded · Hold → Buy · 2026-05-20
$200.00
+33.60%
Wells Fargo
Reiterated · Overweight · 2026-04-30
$185.00
+23.60%
Barclays
Reiterated · Overweight · 2026-04-30
$210.00
+40.30%
JP Morgan
Reiterated · Overweight · 2026-04-30
$87.00
−41.90%
B of A Securities
Reiterated · Buy · 2026-03-27
—
—
Freedom Broker
Reiterated · Hold · 2026-02-02
—
—
Benchmark
Reiterated · Buy · 2026-01-30
—
—
Goldman Sachs
Reiterated · Neutral · 2025-10-30
$149.00
−0.50%
Deutsche Bank
Reiterated · Buy · 2025-10-02
$220.00
+47.00%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2025-07-01
$196.00
+30.90%
TD Securities
Reiterated · Hold · 2025-05-01
—
—
Loop Capital
Reiterated · Buy · 2023-08-18
—
—
Credit Suisse
Reiterated · Underperform · 2023-08-16
$93.00
−37.90%
Keybanc
Reiterated · Overweight · 2023-01-11
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2023-01-05
—
—
Vertical Research
Downgraded · Hold → Sell · 2022-08-17
—
—
Bank of America
Downgraded · Neutral → Underperform · 2019-10-30
—
—
KeyBanc
Downgraded · Overweight → Sector Weight · 2019-02-27
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-08-03
$225.00
+50.30%
BB&T Capital
Downgraded · Buy → Hold · 2016-04-27
—
—
Buckingham Research
Reiterated · Buy · 2016-04-21
—
—
RBC Capital
Upgraded · Sector Perform → Outperform · 2016-01-07
—
—
Cleveland Research
Downgraded · Buy → Neutral · 2015-03-11
—
—
Nomura
Reiterated · Neutral · 2014-12-10
—
—
Macquarie
Reiterated · Neutral · 2014-10-15
—
—
Edward Jones
Upgraded · Sell → Hold · 2014-07-31
—
—
FBR Capital
Upgraded · Underperform → Market Perform · 2014-03-31
—
—
Wunderlich
Reiterated · Hold · 2014-02-06
—
—
Wunderlich Securities
Reiterated · Hold · 2014-02-06
—
—
Sterne Agee
Reiterated · Buy · 2012-10-23
—
—
Longbow Research
Reiterated · Neutral · 2012-08-09
—
—
Avondale Partners
Downgraded · Outperform → Market Perform · 2012-07-25
—
—
Oppenheimer
Reiterated · Perform · 2012-05-11
—
—
One row per institution · price target from the firm's latest published target